Client Name - : Axelia Solutions PVT LTD - PP0564
Client Name - : Axelia Solutions PVT LTD - PP0564
Client Name - : Axelia Solutions PVT LTD - PP0564
RBC Morphology
Absolute Count
Absolute Neutrophil Count 3.8 * 1049/L, 2.0-7.0
Absolute Lymphocyte Count 1.8 * 10°9/L 1-3
Absolute Monocyte Count 0.3 * 1049/L 0.2-1.0
Absolute Eosinophil Count 0.4 * 1049/L 0.0-0.5
Absolute Basophils Count 0.1 * 1049/L, 1-2
WBC Within normal limits
Page1 of 6
ID : 148428 Collection : 14/06/19, 07:11 PM Client Name Axelia Solutions Pvt Ltd -
Name Received: 14/06/19, 07:11 PM PP0564
Age :29 years Reported : 14/06/19, 08:40 PM Client Address : Mumbai
Gender : Female Ref. Doctor : SELF Ill IU0 | Ill
(especially severe irondeficiency and haemolytic), chronic renalfailure andliver diseases. Clinical correlation suggested.
In knowndiabetic patients, following values can be considered as a toolfor monitoring the glycemic control.
me
Excellent control-6-7 %
Fair to Goodcontrol — 7-8 %
Unsatisfactory control — 8 to 10 %
Poor Control — More than 10 %
Page2 of 6
ID : 148428 Collection : 14/06/19, 07:11 PM Client Name _ : Axelia Solutions Pvt Ltd -
Name Received: 14/06/19, 07:11 PM PP0564
Age :29 years Reported : 14/06/19, 08:40 PM Client Address : Mumbai
Gender : Female Ref. Doctor : SELF Ill IU0 | Ill
Creatinine, Serum
Triglycerides, Serum
Page3 of 6
ID : 148428 Collection: 14/06/19, 07:11 PM Client Name _: Axelia Solutions Pvt Ltd -
Name Received: 14/06/19, 07:11 PM PP0564
Age : 29 years Reported —: 14/06/19, 08:40 PM Client Address : Mumbai
Gender : Female Ref. Doctor : SELF
111906599209
Test Description Value(s) Unit(s) Reference Range
IMMUNOLOGY
1. Serum TSH concentrations exhibit a diurnal variation with the peak occurring during the night.
2. Useful for:Screeningforthyroid dysfunction and detecting mild (subclinical), as well as overt, primary hypo- or hyperthyroidism in
ambulatory patients.
3. Monitoring patients on thyroid replacementtherapy.
4. Confirmationof thyroid-stimulating hormone (TSH)suppressionin thyroid cancerpatients on thyroxine suppression therapy.
5.Predictionof thyrotropin-releasing hormone-stimulated TSH response.
Insulin, Fasting
Page4 of 6
ID : 148428 Collection : 14/06/19, 07:11 PM Client Name Axelia Solutions Pvt Ltd -
Name Received: 14/06/19, 07:11 PM PP0564
Age :29 years Reported : 14/06/19, 08:40 PM Client Address : Mumbai
Gender : Female Ref. Doctor : SELF Ill IU0 | Ill
Vitamin D, 25 - Hydroxy
Page5 of 6
ID : 148428 : 14/06/19, 07:11 PM Client Name _ : Axelia Solutions Pvt Ltd -
Name : 14/06/19, 07:11 PM PP0564
Age : 29 years : 14/06/19, 08:40 PM Client Address : Mumbai
Urine Examination-Routine
Urine Examination-Routine
**END OF REPORT**
Page6 of 6